BIB

ProShares Ultra Nasdaq Biotechnology (BIB) | Rumor.io

ProShares Ultra Nasdaq Biotechnology

BIB

Attention (50-day avg)0%

Attention rank (50-day avg)#1,536

Bullish sentiment (50-day avg)87%

Price to earnings ratio32.4

Net assets0

Expense ratio0.01%

Social

What share of all ETF conversation is about BIB?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% new	0% +0

Jun 22

The ProShares Ultra Nasdaq Biotechnology ($BIB) is running hot, with a possible correction expected before a sustained rally.
The biotech sector ($IBB, $BIB) has seen strong buying for four days in a row, with a pullback potentially offering a better entry point.
A short-term pause is possible if $BIB gaps up into its 50% line at 320.41, but a small correction could be normal before a continued rally.

Generated by AI

Sentiment

Of the messages about BIB that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100% 0	86.67%	81.9% -10.6
Bearish	0%	0% 0	13.33%	18.1% +10.6

Bullish· Nov 9

The election of Donald Trump has created a buying opportunity for $BIB, with the company potentially benefiting from his administration's policies.
$BIB may see increased momentum without Hillary Clinton's influence, suggesting a positive outlook for the stock.
A potential support level for $BIB is near $46, making it a key price to watch for investors.

Bearish· Sep 29

Biotech stocks, including $BIB, are experiencing a correction due to bubble-like valuations not seen since 2000.
$BIB is experiencing significant losses, with one investor stopping out for a loss and another selling their entire position.
$BIB is expected to experience short-term pain, with one investor suggesting that any moves up should be sold until lower levels are reached in broader markets.

Generated by AI

Topics

Of the messages about BIB that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Technical Analysis	100%	100%	100%	95.4%
Macro	0%	0%	0%	4.6%

Nov 9

$BIB has been identified as a potential winner due to the uncertainty surrounding the presidential election.
The stock has seen significant selling pressure, but buying volume is still needed to catch up and potentially drive prices higher.
Technical analysis has indicated a bearish trend for $BIB, with recent alerts suggesting a retraction and potential opportunities for reentry in the future.

Generated by AI

Community

Of the messages about BIB, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	96.88%	64.36%
Newcomers	0%	0%	3.13%	35.64%

Regulars· Mar 2

$BIB is mentioned in a post discussing a whistleblower award to a high-frequency trading expert and critic, implying that the expert's work may have implications for the markets, particularly those focused on biotechnology like $BIB.
The post also references $BBH, a stock often associated with market manipulation, which may be of interest to regulars focused on $BIB.
There is also a mention of $BIB in a post listing various stock symbols, including $SALT, $TZA, and $TCK/B.TO, which may be of interest to regulars as a trade idea.

Newcomers· Oct 5

New users are noticing a change in the National Semiconductor Exchange Index ($NSEH), which could impact the ProShares Ultra Nasdaq Biotechnology ($BIB).
Some newcomers are discussing the news from PSRU, which may affect the ProShares Ultra Nasdaq Biotechnology ($BIB) holdings.
A few newcomers are comparing the previous close price of the ProShares Ultra Nasdaq Biotechnology ($BIB) to other stocks like FNMA and CIVI.

Generated by AI

Also Discussed

Investors talking about BIB also mention

#	Name	Attention
1	ProShares UltraShort Nasdaq BiotechnologyBIS	0%0
2	iShares Biotechnology ETFIBB	0.01%0
3	VanEck Biotech ETFBBH	0%new
4	Direxion Daily Healthcare Bull 3X SharesCURE	0%0
5	SPDR S&P Biotech ETFXBI	0.42%+0.08
6	Direxion Daily S&P Biotech Bull 3X SharesLABU	0.01%+0.01
7	First Trust NYSE Arca Biotechnology Index FundFBT	0%0
8	Vanguard Health Care ETFVHT	0.13%+0.12
9	Direxion Daily S&P Biotech Bear 3X SharesLABD	0.01%+0.01
10	Direxion Daily Energy Bull 2X SharesERX	0%new

ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology is a leveraged exchange-traded fund designed to provide daily investment results that correspond to two times the daily performance of the Nasdaq Biotechnology Index. ProShares Ultra Nasdaq Biotechnology focuses on U.S.-listed biotechnology and pharmaceutical companies, giving investors concentrated exposure to a sector that spans drug development, life sciences, diagnostics, and related healthcare innovation. The fund uses derivatives to achieve its leveraged objective and is structured as a non-diversified ETF. Its portfolio typically includes a broad mix of biotechnology and pharmaceutical issuers across different market capitalizations, making it a specialized vehicle for gaining amplified exposure to the biotechnology industry within the broader healthcare market. ProShares Ultra Nasdaq Biotechnology is used primarily by market participants seeking tactical, short-term sector exposure rather than broad market diversification.

Location

United States

Social

What share of all ETF conversation is about BIB?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% new	0% +0

Jun 22

The ProShares Ultra Nasdaq Biotechnology ($BIB) is running hot, with a possible correction expected before a sustained rally.
The biotech sector ($IBB, $BIB) has seen strong buying for four days in a row, with a pullback potentially offering a better entry point.
A short-term pause is possible if $BIB gaps up into its 50% line at 320.41, but a small correction could be normal before a continued rally.

Generated by AI

Sentiment

Of the messages about BIB that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100% 0	86.67%	81.9% -10.6
Bearish	0%	0% 0	13.33%	18.1% +10.6

Bullish· Nov 9

The election of Donald Trump has created a buying opportunity for $BIB, with the company potentially benefiting from his administration's policies.
$BIB may see increased momentum without Hillary Clinton's influence, suggesting a positive outlook for the stock.
A potential support level for $BIB is near $46, making it a key price to watch for investors.

Bearish· Sep 29

Biotech stocks, including $BIB, are experiencing a correction due to bubble-like valuations not seen since 2000.
$BIB is experiencing significant losses, with one investor stopping out for a loss and another selling their entire position.
$BIB is expected to experience short-term pain, with one investor suggesting that any moves up should be sold until lower levels are reached in broader markets.

Generated by AI

Topics

Of the messages about BIB that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Technical Analysis	100%	100%	100%	95.4%
Macro	0%	0%	0%	4.6%

Nov 9

$BIB has been identified as a potential winner due to the uncertainty surrounding the presidential election.
The stock has seen significant selling pressure, but buying volume is still needed to catch up and potentially drive prices higher.
Technical analysis has indicated a bearish trend for $BIB, with recent alerts suggesting a retraction and potential opportunities for reentry in the future.

Generated by AI

Community

Of the messages about BIB, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	96.88%	64.36%
Newcomers	0%	0%	3.13%	35.64%

Regulars· Mar 2

$BIB is mentioned in a post discussing a whistleblower award to a high-frequency trading expert and critic, implying that the expert's work may have implications for the markets, particularly those focused on biotechnology like $BIB.
The post also references $BBH, a stock often associated with market manipulation, which may be of interest to regulars focused on $BIB.
There is also a mention of $BIB in a post listing various stock symbols, including $SALT, $TZA, and $TCK/B.TO, which may be of interest to regulars as a trade idea.

Newcomers· Oct 5

New users are noticing a change in the National Semiconductor Exchange Index ($NSEH), which could impact the ProShares Ultra Nasdaq Biotechnology ($BIB).
Some newcomers are discussing the news from PSRU, which may affect the ProShares Ultra Nasdaq Biotechnology ($BIB) holdings.
A few newcomers are comparing the previous close price of the ProShares Ultra Nasdaq Biotechnology ($BIB) to other stocks like FNMA and CIVI.

Generated by AI

ProShares Ultra Nasdaq Biotechnology

Social

Jun 22

Sentiment

Bullish· Nov 9

Bearish· Sep 29

Topics

Nov 9

Community

Regulars· Mar 2

Newcomers· Oct 5

Also Discussed

ProShares Ultra Nasdaq Biotechnology

Company Information

Location

Also Discussed

Social

Jun 22

Sentiment

Bullish· Nov 9

Bearish· Sep 29

Topics

Nov 9

Community

Regulars· Mar 2

Newcomers· Oct 5